ABOUT EVENT

What’s in store this year?

The 5th Inner Ear Disorders Therapeutics Summit is the only industry-focused meeting dedicated to drug development for acquired and genetic hearing disorders, offering a unique platform to share progress and challenges beyond academic research.

Bringing together experts from Regeneron, Biogen, Acousia, Rinri, Ting Therapeutics, and more, this intimate, collaborative forum is designed for drug developers tackling translational hurdles in moving therapies from preclinical to clinical stages.

Discussions will focus on advancing human-relevant models, uncovering druggable pathways, evaluating gene therapy progress, overcoming translational barriers for small molecules and cell-based therapies, and exploring drug-device combinations to enhance cochlear implants. Unlike larger academic conferences, this summit fosters pre-competitive collaboration, allowing for deeper industry-driven discussions on de-risking opportunities and accelerating innovation in hearing restoration.

Join 50+ biotech leaders, pharma stakeholders, and medical device pioneers in shaping the future of otoprotection, gene therapy, and hearing loss treatment.

VIEW EVENT GUIDE

What's New?

Unparalleled Industry Collaboration: Join 50+ experts from leading companies like Regeneron, Biogen, Acousia, and Rinri, offering a unique opportunity to benchmark learnings from past challenges, foster new partnerships, and ignite progress in hearing loss therapeutics.

Pioneering Insights on Gene Therapy and Cell Transplants: Dive into cutting-edge discussions on gene therapy advancements and the future of cell-based therapies, addressing unmet needs in hearing restoration and showcasing the potential of these breakthrough treatments.

Exploring Druggable Pathways for Hearing Loss: Gain a deeper understanding of molecular and genetic pathways driving age-related, noise-induced, and congenital hearing loss, uncovering new druggable targets to accelerate therapeutic development.

Overcoming Translational Challenges in Hearing Restoration: Evaluate the latest clinical advancements and address translational bottlenecks to bring novel therapies, including small molecules and cell-based solutions, from the lab to the clinic.

Strategic Insights from Pharma and Investors: Hear from large pharma and investors on what needs to be demonstrated to de-risk business opportunities in the hearing disorders space, ensuring strategic growth and investment potential for your innovations.

Who Will You Meet?

Join 50+ biotech and pharma stakeholders, with expertise spanning preclinical, translational and clinical development, as well as leading academics, VCs and patient groups, in one intimate and collaborative environment.

What Your Peers Have to Say

"I look forward to participating in the Inner Ear Disorders Therapeutics summit, which provides a unique platform for leaders from academia, biotech and industry to discuss translational science and medicines for hearing disorders. Both the symposia and poster sessions are highly interactive and provide excellent forums for engaging and networking with authoritative leaders”

Rapport Therapeutics

''The Inner Ear Disorders Therapeutics Summit is crucial for staying updated and connected in our field. The focused sessions and thorough discussions help us at Spiral Therapeutics align our strategies with global advancements in treating hearing disorders. It's an excellent place for real insights and meaningful collaboration.''

Spiral Therapeutics

EVENT GUIDE
REGISTER
PARTNER